Cytokine production in panic disorder patients

Clinical Neuropharmacology

Volumn 22, Issue 2, 1999, Pages 107-109

  Weizman, R ^a   Laor, N ^a   Wiener, Z ^a   Wolmer, L ^a   Bessler, H ^a  

^a NONE   (Israel)

Author keywords

Agoraphobia; Anxiety; Cytokines; Interleukin 2; Interleukin 3; Panic disorder

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 3;

ADULT; AGORAPHOBIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PANIC; PRIORITY JOURNAL; STRESS;

EID: 0033303298     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199903000-00008     Document Type: Article

References (15)

1. Systemic interleukin-1 and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans
2. Comparative study of immune status in panic disorder patients and controls
3. Lymphocyte function in panic disorder
4. Immunity, major depression and panic disorder comorbidity
5. Psychoimmunoendocrine aspects of panic disorders
6. Serum cytokine and soluble interleukin-2 receptors in patients with panic disorder
7. An inventory for measuring depression
8. Cytokine production in obsessive-compulsive disorder
9. The DST in psychiatric outpatients with generalised anxiety disorder, panic disorder, or primary affective disorder
10. Normal dexamethasone suppression test in OCD
11. Multiple and reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal-axis in depression
12. Cytokine production in major depressed patients before and after clomipramine treatment
13. The stress response and autoimmuno-regulation